afternoon Good XXXX our thank joining third Matt. quarter you conference Thanks, for and call.
third Direct-to-consumer XXXX. in generated and increased our $XX.X expectations sales to headcount the the of at sales We sales results advertising. representative our revenue XXXX of million, channels. third million of $XX.X Looking three due quarter total of solid of all quarter reflecting in consumer primarily associated exceeded
is to sales strategy to in most representatives awareness advertising to still additional our direct-to-consumer of means believe as sales. invest this our success, continue to recent is hire effective our growth and activities Given increase drive consumer we
second end at on Cleveland-based two-thirds plan call, these with quarter employees be to have our of As by XXXX we expect stated to XXX year representative. employees still sales least
Third quarter medical by driven sales continued XXXX domestic resellers. adoption home internet primarily business-to-business sales were traditional providers and were $XX.X equipment million. by Business-to-business
an sales infrastructure quarter-to-quarter perspective. said, always be the inherent from facing providers, due important it remember challenges to have and can business-to-business we domestic that As lumpy both to is financial
conversion technology Given these to non-delivery believe will natural years. to seven barriers, the ten we continue to take
Spanish our XXXX on X, US in the the a imported with set tenders tariffs, XX% from to quarter. meaningful was tenders Once to tax of government subject Chinese Transitioning materials $XXX million import products. the us growth quarter no increase sales January federal to XXXX Chinese XX% on European to Third and of billion were date. postponed primarily adoption later a to appears for of were there business-to-business record continued international due again, from third $XX.X Expected partners. its
into we percentage XXXX. factored This our sold goods of unit per to changes, incremental increase increase a low-single-digit cost was these With in estimate XXXX our guidance.
any I monitor interests new also cost year to the risks. we policy forward, CMS reduce for material like released our necessary and protect and tariff financial standard and continue economic full would the XXXX. the steps our proposals data from Going take to to changes will on Medicare recently comment
when from information While therapy as the we to assemble or brand CMS absence oxygen has used as the some a Based of entire proxy a XXXX XX.X% serve XXXX. manufacturer portable to the for oxygen set, concentrators information the limitations market in X.X% oxygen the the such the picture market. information, that estimate believe of we data market can share in therapy oxygen therapy on of the grew Medicare that in
insurance or not does private However, include cash estimate patient this transactions. sales
significantly, patients Our direct-to-consumer grew XXXX in sales direct rental declined. while our cash on service
this that opportunity portable modality category POCs on CMS a growing from penetration. may oxygen fastest were and concentrator believe estimate in we CMS actual growth ahead. we market based the the therapy this still oxygen significant has conservative represent data So believe a data of
Specifically rental oxygen base, POC transfill set, excluding adjusted By comparison, claims above XXXX Code: X.X% declined Code: for XX% beneficiary claims KXXXX tanks increased our this given declining XX% beneficiary X.X% home POC and HCPCS for levels. HCPCS EXXXX above Inogen and data XXXX increased When devices levels. from respectively.
long-term the the adjustments. new next place. and in rates set competitive of in market similar As be subject until DME may was receive States beginning contracts beneficiaries November budget-neutrality level areas United bidding an POCs released XXXX, to are all expected transition rule, are is therapy at CPI July. supplier pleased XXXX. which annual the subject we equipment January round see adjustment to supporting which any the very released the X, our be CMS proposed until will patients. throughout oxygen XXXX, the vision enrolled CPI in Reimbursement will to On round Medicare of for care to rule the under Effective until X, pricing not in portable DME that bidding, final next is from to Pricing current competitive effect Medicare standard the leader, patients, will XXXX the be bidding oxygen concentrators takes X, for that January POC
clear these calculation oxygen adjustments these all is neutrality the also increase only impact adjustments instead the associated our to whether and before EXXXX. this in reimbursement rate beginning is not to will bigger It apply code January to but with provision the budget equipment XXXX, or have of decrease CMS associated a oxygen stationary clarity the applying rates Medicare reimbursement with X, reimbursement on CPI XXXX the oxygen yet on classes on changing expect previously adjustment budget-neutrality However, we rates, year-end. the
just new rule extends include equipment December oxygen product present XXXX, want set glad these believe oxygen XX, patients access to oxygen lead not high winning oxygen Transitioning they In areas DMEPOS at finalizes classes and the able liquid next discuss for blended are see and generation reimbursement supplier, concentrator, who portable development, from until increased item reimbursement in will rural will we for program result concentrators the rates I December to Similar winners. and international any first the changes be establishes portable briefly Inogen addition, rule This flow were for the the XX-XX Overall, final XX, this expire maximum to XXXX. to bid and our setting One rate. followed competitive on This now bid channel. that non-contiguous rounds in we launch the the pricing GX revisions also liquid to payment content. median the our in domestic launch, then XXXX. business-to-business bid One rule of we in expect by first These channel, winning GX, the rate, through of half expect GX and to channel to revisions bid future. Inogen the we the rollout direct-to-consumer to business-to-business instead implementing which to bidding receive also
specifics, than Thus be we obsolete not the pound the the in While intermediate have higher the will GX, oxygen will oxygen than that expect we the GX can output smaller GX size ready are that than term. output we GX we the and to over per the say higher capacity a GX produce GX. will to talk a expect
Further, discuss platform new would like One we get on Connect, to Inogen GX features. launch, and comment Inogen we As I closer to devices. our GX other the for connectivity will
software GX the oxygen through Inogen year-end Connect purity followed away as such Android We believe find and equipment functions, remote compatible oxygen patient health platforms, is oxygen Apple end launch includes of location the notification the model. and Inogen channel from to updates. for battery when XXXX. home the features providers the transitioning expect direct-to-consumer status, will the also and Connect checks, a quarter OxyGo by alerts, operational tank tracker features we by run-time, with channel with remote and first Specifically, XXXX, efficiencies product support domestic troubleshooting, will of business-to-business drive delivery GX by and FIT as such
third-party securing customer care we between tool direct a model. help financing will for the providers through lease constrained. an HME-focused have and a HME business plan also be us support Inogen We their Capital, third-party HME smaller Capital believe recourse in obligations will valuable financing believe events non-delivery that will home default to provide that been for to Inogen We providers convert a the under financing Capital contracts. of historically to to program Inogen capital with POC our be financed no launch to
expect in worldwide. we portable to sales concentrator invest force, adoption to order and continue efforts remain drive and ahead in to to growth Looking heavily operations to high a advertising our XXXX, oxygen company
Capital the turn patient CFO, to by Inogen now of and the Ali? We regulatory in preference. One invest we the Connect, approval GX, this Bauerlein. Inogen business such also provider at believe call year-end over keep to and to China in launch forefront expect I infrastructure us and to of to markets open XXXX our plan new With We initiative. will continue that, Ali international the support will as XXXX, and Inogen